Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ADC Antibody
    (1)
Filter
Search Result
Results for "

inebilizumab

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
Inebilizumab
VIB-0551, MT-0551, MEDI 551, 16C4-aFuc
T767131299440-37-1
Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19 B cells, such as multiple sclerosis and optic neuromyelitis.
  • Inquiry Price
Size
QTY
Inebilizumab (FUT8-KO)
T9901A-130
Inebilizumab(FUT8-KO) is a modified version of inebilizumab that features a knocked-out fucosyltransferase 8 gene (FUT8). This anti-CD19 monoclonal antibody (mAb) exhibits enhanced antibody-dependent cell-mediated cytotoxicity against B cells, making it suitable for research into multiple sclerosis and neuromyelitis optica.
  • Inquiry Price
2-4 weeks
Size
QTY